ArticleEuropean journal of medical research2025
Exploring the predictive value of mammography combined with clinical factors in recurrent metastasis of breast cancer.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study was to construct a radiomics nomogram based on mammography (MG) combined with clinical factors for the prediction of recurrent and metastasis in breast cancer. A total of 762 patients, all diagnosed with pathologically confirmed and undergoing MG examination, was encompassed within this article. These patients were initially diagnosed at the Affiliated Cancer Hospital of Xinjiang Medical University between January 1, 2018, and December 31, 2022, the patients were Randomly divided in a 7:3 ratio into a training set of 534 cases and a validation set of 228 cases. Using the collected data, a combined predictive model was established based on statistical methods. In forecasting the recurrence of metastasis in breast cancer, the combined model (AUC of 0.851 and 0.809 for the training and validation sets, respectively) had a higher predictive performance compared to the clinical model (AUC of 0.757 and 0.753 for the training and validation sets, respectively) and the imaging histology model (AUC of 0.802 and 0.748 for the training and validation sets, respectively).The combined model outperforms the single-modal model in terms of efficacy, which can be used as an important reference for clinically determining the prognosis of breast cancer patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.